Heal, David J. http://orcid.org/0000-0002-6128-9632
Gosden, Jane
Article History
Received: 17 June 2020
Revised: 1 November 2021
Accepted: 18 November 2021
First Online: 7 January 2022
Competing interests
: DJ Heal and J Gosden are shareholders and employees of DevelRx Ltd. DevelRx provides consultancy to the pharmaceutical industry in a range of areas including the discovery and development of new drugs to treat binge-eating disorder. The authors received no external financial or logistical support when writing this manuscript. The opinions expressed are those of the authors and have not been influenced by any commercial organisation.